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ABSTRACT
Background    Bile leakage after hepatectomy is a com-
mon complication. The purpose of the present study was 
to retrospectively evaluate the usefulness of non-surgical 
management of bile leakage after hepatectomy, using 12-
year data from a single center study.
Methods    Data from 15 patients (13 men, two women; 
mean age 67.1 ± 7.0 years) who had undergone non-
surgical management for bile leakage between January 
2005 and November 2017 were retrospectively reviewed.
Results    We categorized bile leakage as central (n = 5) 
or peripheral (n = 10) leakage based on communication 
with the biliary tree. Percutaneous bile leakage drainage 
and/or endoscopic naso-biliary drainage (ENBD) (n = 2) 
or the rendezvous technique (n = 3) was successfully per-
formed in five central-type cases, while all peripheral-type 
cases were treated with drainage alone; only one case 
required additional ethanol ablation. Bacterial bile cultures 
were positive in 11 cases and negative in four cases. The 
drainage catheters were removed after complete resolution 
in 13 cases (86.7%), while two patients with cases of 
peripheral-type leakage died due to cancer progression 
while the drain was in place. No case needed conversion 
to reoperation. The mean duration of drainage therapy in 
all cases was 210.1 ± 163.0 days (range 17–531 days), with 
316.8 ± 180.8 days in the central type and 156.7 ± 131.5 
days in the peripheral type; this duration was not signifi-
cantly different (P = 0.129).
Conclusion    Non-surgical treatment is a minimally 
invasive and effective management strategy for postop-
erative bile leakage and the modality used depends on 
the type of bile leakage encountered.
Key words    bile leakage; endoscopic naso-biliary 
drainage; percutaneous bile leakage drainage; percutane-
ous transhepatic biliary drainage; rendezvous technique
Bile leakage after hepatectomy is a common complica-
tion with an incidence rate of 2.9%–17%.1–9 The causes 
of bile leakage include cholerrhagia from the transected 
edge of the liver and sutural leakage after biliary tract 
rebuilding, among others. Bile leakage is also associated 
with serious biliary infection, and the resulting sepsis 
and septic shock are associated with high morbidity 
and mortality, impaired quality of life, and a substantial 
financial burden on both patients and society.2, 10 Some 
previous literatures had reported some interactive cases 
as much volume of bilious discharge or major injury 
of biliary tree required repeat operation. However, the 
reoperation was considered to be risky and invasive ex-
tremely. Furthermore, surgical therapy for bile leakage 
in the postoperative period increases patient morbidity 
and mortality.11, 12 Recently, treatment strategies for bile 
leakage have undergone fundamental changes due to the 
excellent results achieved using non-surgical manage-
ment and minimally invasive interventions.1, 2, 5 Thus, 
currently, non-surgical treatment is regarded as the first 
choice in the management of postoperative bile leakage 
in a majority of cases, and these include modalities 
such as percutaneous bile leakage drainage (PBLD), 
biliary fistula ablation, endoscopic naso-biliary drainage 
(ENBD), or percutaneous transhepatic biliary drainage 
(PTBD). Sakamoto et al had reported excellent result 
of non-surgical treatment for postoperative bile-leakage 
cases, which was divided into two categories as with and 
without communication with the biliary tree. However, 
some of interactive cases needed surgical therapy in the 
postoperative period.1
 Thus, the purpose of this study was to retrospectively 
evaluate the usefulness of non-surgical management of 
bile leakage after hepatectomy divided into two catego-
ries, based on data from 15 patients treated over a period 
of 12 years at our hospital.
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MATERIALS AND METHODS
Ethics
This study was approved by the ethics committee of 
Tottori University (Approval No. 1BA139). 
Patients
Patient characteristics are summarized in Table 1. 
Fifteen consecutive patients (13 men, two women; 
mean age 67.1 ± 7.0 years; range, 52 to 80 years) with 
bile leakage after open hepatectomy without biliary 
reconstruction were treated using non-surgical methods 
between January 2005 and November 2017 at our hospi-
tal and their charts were reviewed retrospectively. Of the 
15 patients, seven (46.7%) had hepatocellular carcinoma 
(HCC), seven (46.7%) had liver metastases, and one 
case (6.7%) involved a hilar cholangiocarcinoma. Liver 
metastases were from gastric cancer in two cases (13.3%), 
colon cancer in four cases (26.7%), and an undifferenti-
ated high grade pleomorphic sarcoma in one case (6.7%). 
A partial hepatectomy or segmentectomy (segments 2, 3, 
4, 7, or 8) had been performed in fi ve cases (33.3%), an 
anterior sectionectomy in four cases (26.7%), a posterior 
sectionectomy in two cases (13.3%), an extended hepa-
tectomy or left hepatectomy in two cases (13.3%), a right 
hepatectomy in one case (6.7%), and a central bisectio-
nectomy in one case (6.7%). The sites of bile leakage 
were at the transected edge of the liver in all cases.
Procedure
Our strategy for non-surgical treatment of bile leakage 
is shown in Fig. 1. Abdominal drains that had been 
placed during surgery were removed a few days post 
procedure, when the drain fl uid was grossly serous and 
had gradually decreased or disappeared. If bile leakage 
was suspected based on symptoms such as high fever 
or jaundice, a computed tomography (CT) scan was 
performed to detect abdominal fl uid collection. If bile 
leakage was indeed detected, PBLD using an 8.5Fr 
drainage catheter (Dawson-Mueller Multipurpose 
Drainage Catheter, Cook Medical, Bloomington, IN) 
and/or endoscopic retrograde cholangiography (ERC) 
was performed under CT guidance. In this study, we 
classifi ed post-operative bile leakage into two categories, 
according to Sakamoto’s classification.1 If the leaky 
bile ducts were confi rmed to be in communication with 
the biliary tree, either by fistulography via the PBLD 
catheter or by endoscopic retrograde cholangiography 
(ERC), such leakage was defined as “central-type,” 
whereas leaky bile ducts that were not in communication 
with the biliary tree were defi ned as “peripheral-type.” 
Appropriate antibiotic therapy was administered based 
on bacterial cultures of the drainage fl uid.
 In patients with central-type leakage, ENBD was per-
formed as an initial biliary intervention using 5.0 to 6.0 Fr 
drainage catheter (Flexima, Boston Scientifi c, Watertown, 
MA) to divert bile fl ow away from the leakage site and 
reduce bile duct pressure. When bilious discharge from 
the drainage catheter was greater than 100 mL per day 
and persisted for several weeks after the initial diverting 
procedure or if the catheter could not be placed across the 
bile leakage site, PTBD using an 8.5Fr drainage catheter 
(Dawson-Mueller Multipurpose Drainage Catheter, Cook 
Medical, Bloomington, IN) was performed to addition-
ally decompress the biliary tree. If the drainage catheter 
could not be placed across the site of bile duct injury, the 
rendezvous technique was performed using two separate 
pathways, wherein both endoscopic and percutaneous bile 
duct access routes to reach one common site were created, 
with subsequent capture of the trailing end of one access 
wire with a snare catheter was positioned through the 
second access site.13–16
 In patients with non-effective peripheral-type leak-
age, if bilious discharge greater than 100 mL per day 
from the drainage catheter persisted for several weeks, 
ethanol ablation therapy for a biliary fistula via PBLD 
tube was considered as the additional biliary intervention.
 In patients with central- or peripheral-type leakage, 
Table 1. Baseline Characteristics of 15 cases
Parameter Value, No. of patients
Age in years 67.1 ± 7.0 (52–80)
Gender
Male 13 (86.7%)
Female 2 (13.3%)
Disease
HCC 7 (46.7%),
Liver metastases 7 (46.7%)
Gastric cancer 2 (13.3%)
Colon cancer 4 (26.7%)
Undifferentiated high grade pleomor-
phic sarcoma 1 (6.7%)
Hilar cholangiocarcinoma 1 (6.7%)
Type of hepatectomy
Partial hepatectomy or segmentectomy 
(2, 3, 4, 7, 8) 5 (33.3%)
(Extended) left hepatectomy 2 (13.3%)
Anterior sectionectomy 4 (26.7%)
Posterior sectionectomy 2 (13.3%)
Right hepatectomy 1 (6.7%)
Central bisectionectomy 1 (6.7%)
Sites of bile leakage
Transection edge of liver 15 (100%)
Values represent mean ± SD (range) or number (%). HCC, hepato-
cellular carcinoma.
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a fistulography and/or cholangiography was regularly 
performed once every one or two weeks to confirm 
resolution of bile leakage. A reoperation was considered 
only if these treatments failed.
 The drain was clamped when bilious discharge from 
drainage catheter had ceased, if bile leakage had re-
duced signifi cantly, or if it had almost disappeared when 
evaluated in a CT scan. Finally, the drain was removed 
only when there was no recurrence of symptoms and no 
elevation of biochemical parameters such as a bilirubin, 
a biliary enzyme and an infl ammatory response.
Analysis
The medical records and endoscopic and radiologic 
findings were reviewed retrospectively. Clinical pa-
rameters, including type of hepatectomy, central- or 
peripheral-type leakage, bacterial cultures, the necessity 
for additional biliary intervention, and mean duration of 
continuous drainage therapy were evaluated using the 
F-test and Student’s t-test. P-values < 0.05 were consid-
ered statistically significant. IBM SPSS statistics 22.0 
software (IBM Corporation, Armonk, NY) was used for 
all statistical analyses.
RESULTS
The outcomes after non-surgical therapy for bile leakage 
are provided in Table 2 and Fig. 2. Also, the outcomes 
between the central-type and peripheral-type groups are 
provided in Table 3. Initial biliary intervention could be 
successfully performed in all 15 cases. Among the 15 
patients with confirmed bile leakage, central-type and 
peripheral-type leakages were observed in fi ve (33.3%) 
and 10 (66.7%) cases, respectively. In both central- and 
peripheral-type leakage, fistulography and/or cholan-
giography was performed to confirm cessation of bile 
leakage every one or two weeks. 
 For all cases combined, the mean interval from op-
eration to initial biliary intervention was 68.1 ± 81.9 days 
(13–267 days). The drainage catheter was removed after 
complete resolution and without recurrence of bile leakage 
in 13 cases (86.7%) that were treated by non-surgical meth-
ods alone. The mean duration of drainage therapy for both 
groups combined was 210.1 ± 163.0 days (range 17–531 
days). Both mean interval from operation to biliary inter-
vention and mean duration of continuous drainage therapy 
were not significantly different between the central-type 
and peripheral-type groups (P = 0.897 and P = 0.129, 
respectively). None of the patients required reoperation. 
In patients with central-type leakage, the mean 
interval from operation to initial biliary intervention 
was 64.8 ± 49.7 days (range 13–122 days). PBLD was 
performed prior to ENBD in three cases, and ENBD was 
performed prior to PBLD caused by occlusive jaundice 
in remaining two cases. Two of the five patients with 
central-type leakage were successfully managed using 
PBLD and ENBD, while in the other three cases PTBD 
was required as additional biliary intervention because 
of non-effective drainage or ENBD failure. Further, in 
all these three cases, the drainage catheter for PTBD 
could not be placed across the bile leakage site because 
of a large biliary fistula. Therefore, the rendezvous 
technique was performed on days 14, 14, and 160 after 
initial biliary intervention in these three patients, respec-
tively. The median healing duration for all five cases of 
central-type leakage was 316.8 days (range 145–531 days).
 In patients with peripheral-type leakage, the mean 
interval from operation to initial biliary intervention was 
69.8 ± 96.6 days (16–267 days), and PBLD alone was 
suffi cient for leakage resolution in seven of the 10 cases. 
The median period of healing was 156.7 days (range 
17–411 days). Additional biliary intervention, in the form 
of ethanol ablation for biliary fistula via PBLD, was 
required only in one case and was performed 224 days 
after initial biliary intervention; the fi stula healed after 
355 days. Two cases with peripheral-type leakage died 
due to cancer progression during the median drainage 
period of 316.0 days (range 211–411 days).
 Bacterial cultures from the drainage bile fl uid were 
positive in 11 cases (73.3%) and negative in four cases 
(26.7%); four positive cases of five central-type cases 
(80%), and seven positive cases of ten peripheral-type 
cases (70%), respectively. Of the 11 positive cases, bacte-
ria were of intestinal origin in seven cases (46.7%) and of 
dermal origin in four cases (26.7%). The mean duration 
of continuous drainage therapy was slightly longer in 
the positive group than in the negative group but was not 
Fig.1.
Fig. 1. Non-surgical treatment strategy for bile leakage.This fi gure 
illustrates our strategy of non-surgical treatment for bile leakage. 
*Central type: in communication with a biliary tree; †peripheral 
type: not in communication with a biliary tree. ENBD, endoscopic 
naso-biliary drainage; PBLD, percutaneous bile leakage drainage; 
PTBD, percutaneous transhepatic biliary drainage.
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significantly different (P = 0.197). As limited to the pos-
itive group, the mean duration of continuous drainage 
therapy was slightly longer in the central-type than in 
peripheral-type but was not significantly different (P = 
0.226).
 Figure 3 illustrates the rendezvous technique per-
formed in a 60-year-old male with bile leakage after a 
central bisectionectomy of the liver for HCC. CT images 
at 65 days after surgery showed bile leakage at the tran-
sected edge of the liver. ENBD was initially performed 
Table 2. Outcomes of non-surgical treatment for bile leakage (over all)
Parameter Value, No. of patients P-values
Technical success of initial biliary intervention 15 (100%)
Type of bile leakage
Central-type 5 (33.3%)
Peripheral-type 10 (66.7%).
Mean interval from operation to initial biliary intervention, days 68.1 ± 81.9 (13–267)
Additional biliary intervention
Yes 4 (26.7%) 
No (initial biliary intervention alone) 11 (73.3%)
Mean duration of drainage therapy, days 210.1 ± 163.0 (17–531)
Bile culture
Positive 11 (73.3%)
Bacteria derived from intestine 7 (46.7%)
Bacteria derived from skin 4 (26.7%)
Negative 4 (26.7%).
Mean duration of drainage therapy, days
Positive bile cultivation 238.3 ± 174.1 (77–531) P = 0.197
Negative bile cultivation 132.5 ± 109.5 (17–530) 
Clinical outcomes
Successful removal of drainage catheter 13 (86.7%)
Died with cancer progression remained drainage catheter 2 (13.3%)
Undergoing continuous drainage therapy 0 (0%)
Reoperation 0 (0%)
Values represent mean ± SD (range) or number (%).
Table 3. Outcomes of non-surgical treatment for bile leakage (central-type vs. peripheral-type)
Parameter Central-type (n = 5) Peripheral-type  (n = 10) P-values
Mean interval from operation to initial biliary intervention, 
days 64.8 ± 49.7 (13–122) 69.8 ± 96.6 (16–267) P = 0.897
Additional biliary intervention Rendezvous technique 3 Ethanol ablation 1
Mean duration of drainage therapy, days 316.8 ± 180.8 (145–531) 156.7 ± 131.5 (17–411) P = 0.129
Bile culture Positive 4 Positive 7
Negative 1 Negative 3
Mean duration of drainage therapy with positive group, days 338.3 ± 201.4 (145–531) 181.1 ± 140.6 (17–411) P = 0.226
Clinical outcomes
Successful removal of drainage catheter 5 8
Died with cancer progression remained drainage catheter 0 2
Undergoing continuous drainage therapy 0 0
Reoperation 0 0
Values represent mean ± SD (range) or number (%).
on day 119 after the central bisectionectomy; however, 
the drainage catheter could not be advanced into the 
peripheral bile duct over the injury site. Therefore, 
subsequently, PBLD and PTBD via the lateral inferior 
subsegment branch (B3) were simultaneously performed 
under ultrasonography guidance on day 122 after surgery. 
However, the guide wire could not be advanced into the 
bile duct across the leakage site. Bacterial culture of the 
PBLD drainage fluid yielded intestinal bacteria. Bilious 
discharge of over 300 mL per day from the PBLD per-
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sisted for eight weeks, and a percutaneous fistulogram 
via the drainage catheter demonstrated communication 
with the biliary tree, indicating the presence of a central-
type leakage. Therefore, the rendezvous technique 
was performed on day 136 after surgery, as follows. A 
loop-grasping snare was placed in the PTBD catheter 
and was used to grasp the endoscopic guide wire, which 
was threaded through the ENBD catheter. Subsequently, 
the PTBD catheter was successfully placed over the bile 
leakage site via the rendezvous procedure, bypassing the 
leakage site. A percutaneous fi stulogram via the drainage 
catheter demonstrated persistent communication with the 
biliary tree. Bilious discharge via the PBLD decreased 
gradually and as CT showed the disappearance of bile 
leakage, drainage catheters were successfully removed on 
day 653 post surgery.
DISCUSSION
Bile leakage after hepatectomy is a common complica-
tion with an incidence of 2.9%–17%,1–9 and currently 
non-surgical treatment is being regarded as fi rst choice 
in the management of postoperative bile leakage. 
Effective therapy is selected based on the type of bile 
leakage, which is divided into two categories, as with 
(central-type) and without communication (peripheral-
type) with the biliary tree.1 Central-type leakage is 
predominantly and effectively treated by PBLD and 
ENBD, which reduce internal pressure in the bile duct 
and decrease leakage volume.1–9 A combination of biliary 
intervention therapies, such as the rendezvous technique, 
Fig.2. 
Fig.3.
Fig. 2. Outcomes after non-surgical treatment for bile leakage.
This figure shows the outcomes after non-surgical treatment 
for bile leakage in this study. None of the cases, either with 
central-type or peripheral-type, required continuous drainage 
therapy or conversion to reoperation. *Central type: in communi-
cation with a biliary tree, †peripheral type: not in communication 
with a biliary tree. ENBD, endoscopic naso-biliary drainage; 
PBLD, percutaneous bile leakage drainage; PTBD, percutaneous 
transhepatic biliary drainage.
Fig. 3. A 60-year-old male presented with a bile leakage after cen-
tral bisectionectomy of the liver for hepatocellular carcinoma. (a) 
CT at 65 days after surgery showed bile leakage at the transected 
edge of the liver after central bisectionectomy. (b) ENBD was 
performed 119 days after surgery; however, the drainage catheter 
could not be advanced into the peripheral bile duct over the injury 
site. Subsequently, PBLD (arrow) and PTBD (arrowhead) were 
simultaneously performed via the lateral inferior subsegment 
branch (B3) under US guidance on day 122 after surgery; howev-
er, the guide wire could not be advanced into the bile duct across 
the leakage site. (c) The rendezvous technique was performed 136 
days after surgery, wherein a loop grasping snare (arrow) placed 
into the bile leakage via the PTBD catheter was used to grasp the 
endoscopic guide wire (arrowhead) that was threaded through the 
ENBD catheter. (d) The PTBD catheter was placed over the bile 
leakage site successfully using the rendezvous procedure, thus 
bypassing the leakage site. A percutaneous fistulogram via the 
drainage catheter demonstrated persistence of communication 
with the biliary tree (arrow). (e) CT showed disappearance of bile 
leakage, and drainage catheters were successfully removed on day 
653 after surgery. CT, computed tomography; ENBD, endoscopic 
naso-biliary drainage; PBLD, percutaneous bile leakage drainage; 
PTBD, percutaneous transhepatic biliary drainage.
should also be considered as initial therapeutic options 
in cases that therapeutic effect of PBLD and ENBD is 
insuffi cient. In this study, the rendezvous technique was 
successfully performed after ENBD failure to reduce 
bile duct pressure in three of fi ve central-type cases. All 
central-type leakage cases were resolved within a median 
period of 316.8 days (range 145–531 days). On the other 
hand, for peripheral type leakage, PBLD is fi rst choice 
218
T. Kimura et al.
of treatment. Some intractable cases of peripheral-type 
leakage have been reported to require newer non-surgical 
interventional therapies, including biliary ablation with 
absolute ethanol, because ethanol affects the remaining 
bile duct and causes irreversible damage. In this study, 
all peripheral-type cases, except one, resolved after 
drainage alone and within a median period of 156.7 days 
(range 17–411 days). Only one case required ethanol 
ablation of a biliary fistula through PBLD after drainage. 
Importantly, in both types of leakage, surgical biliary 
reconstruction with strong invasion should only be con-
sidered when there are no essential conditions and if the 
non-surgical management strategies stated above prove 
ineffective.17–19 Further, mismanagement of the condition 
should be avoided in all respects. In this study, all cases 
of bile leakage could be resolved using non-surgical 
methods alone. Sakamoto et al. (2016) had reported some 
cases required the reoperation as the non-surgical treat-
ments failed.1 In our study, none of the cases required 
repeat surgery, because our strategy of bile leakage could 
be more effective than previous reports. We perform 
PBLB, ENBD and PTBD for biliary tract decompression 
positively and also tried to be placed the drainage cath-
eter across a biliary tract failure site by performing the 
rendezvous technique. The reoperation was considered to 
be risky and invasive extremely. Therefore, it is important 
that we were able to avoid much invasive repeat surgery 
by the combined various non-surgical treatments includ-
ing PBLD, ENBD, PTBD and rendezvous technique, 
especially in central-type.
 Sakamoto et al. (2016) have reported that patients 
who underwent segmentectomy 1, medial sectionectomy, 
anterior sectionectomy, or central bisectionectomy were 
found to be at high risk for bile leakage.1 Nagano et al. 
(2003) have demonstrated that hepatectomies, wherein 
the cut surface exposes the major Glisson’s sheath and 
includes the hepatic hilum, are independent risk factors 
for bile leakage.5 However, the correlation between the 
type of hepatectomy and postoperative bile leakage has 
not yet been clearly defined, as is the correlation with 
the occurrence of central- or peripheral-type leakage. 
As hepatectomy including one of the central bisections 
or the hepatic hilum showed a tendency to develop 
central-type leakage, further prospective studies of many 
cases are necessary because of only five central type cases 
in this study. 
 In our study, successful non-surgical management 
of bile leakage was achieved in all 15 patients; this 
corresponds to a cure rate of 86.7% as two patients died 
due to cancer progression with the drainage catheter 
remaining in place. Previous studies have reported cure 
rates that range from 82%–90%, including endoscopic 
management.1, 2, 10, 19–22 The cure rate of drainage therapy 
achieved in our facility is comparable to that of previous 
reports. The mean duration of drainage therapy in our 
study was 210.1 ± 163.0 days, which is similar to that of 
previous reports that ranged from two to 24 months.1, 11, 
18, 21–25 Further, we found that mean duration of drainage 
therapy in central-type leakage tends to be longer than 
that of peripheral-type leakage (316.8 days vs. 156.7 
days, P = 0.129). This observation, in combination with 
the fact that peripheral-type leakage is associated with 
lower leakage volume, probably accounts for why many 
cases of peripheral-type leakage can be resolved by 
PBLD alone. On the other hand, many cases of central-
type several additional biliary intervention including 
PTBD or rendezvous technique combined with initial 
PBLD or ENBD, because initial drainage therapy alone 
is not effective in resolving large leakage volumes. In our 
study, the central-type group required additional biliary 
intervention initially when the drainage volume was higher 
along with greater severity of the clinical course and pro-
traction of the treatment period.
 Cases testing positive for bacterial culture were 
found at almost about the same high frequency in both 
central-type and peripheral-type groups (80% vs. 70%). 
Cases testing positive for bacterial culture tended to have 
a longer duration of drainage therapy than the negative 
group but was not significantly different (238.3 days vs. 
132.5 days, P = 0.197). As limited to the positive group, 
the mean duration of continuous drainage therapy was 
slightly longer in the central-type than in peripheral-type 
but was not significantly different (P = 0.226). Generally, 
bacterial bile infections are treated using antibiotics; 
however, it is often difficult to select appropriate sus-
ceptible antibiotics. Further, the general condition of the 
patient might worsen even if the proper antibiotics are 
administered, thus resulting in longer treatment periods.26 
Therefore appropriate antibiotics should be used until 
cholangitis is improved clinically, and bacterial bile 
leakage can continue until complete recovery in the treat-
ment period, regardless of the bacterial culture results. If 
multiple strategies have been used to resolve bile leakage, 
it is necessary to ensure proper placement of the drainage 
catheter, check for change in cavity size using CT, ERC, 
and PTC, and ascertain the appropriate removal period. 
Importantly, infection-induced ENBD and PTBD should 
also be considered as ENBD may promote a retrograde 
infection at the duodenal papilla and PTBD may increase 
bacterial infection derived from the skin.
 When considered in its entirety, our results indicate that 
non-surgical therapy for bile leakage after hepatectomy is 
adequately efficacious and safe. Nonetheless, as the present 
study is retrospective, the optimal therapeutic strategy for 
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bile leakage could not be identified. Larger prospective 
studies are needed to determine the optimal strategy.
 In conclusion, non-surgical management can be a 
minimally invasive and effective approach for treating 
postoperative bile leakage, but strategy selection should 
be based on whether the leakage is the central-type or 
the peripheral-type. Specifically, as central-type leakage 
is refractory to therapy and require a long time for 
resolution, ENBD, PTBD or the rendezvous technique 
should be considered in central-type leakage to reduce 
bile duct pressure when placed across the bile leakage 
site.
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